Comprehensive Donor Opportunities

Why Give?

The HudsonAlpha Foundation is key to empowering personal health by providing financial support to the talented men and women of the HudsonAlpha Institute. The Foundation advances the Institute’s mission of exploring and growing the knowledge and possibilities of genomics to create meaningful solutions that improve the quality of human, plant and animal life around the world.

Founders James R. Hudson Jr. and Lonnie S. McMillian had a vision in mind when they started the HudsonAlpha Institute for Bitechnology and support is needed in order to keep that vision alive. Since opening its doors in 2008, HudsonAlpha has generated major discoveries that impact disease diagnosis and treatment, created intellectual property, fostered biotechnology companies, and expanded the number of bioscience-literate people, many of whom will be the future workforce. By supporting the Institute, you would be a part of a group of people that want to continue improving the lives of others today and for generations to come.

Endowed chairs are a time-honored means of luring top scientists from other institutions and retaining and rewarding existing faculty. Endowed chairs carry prestige and honor for their chair holders and the persons for whom they are named. Though the cost of endowing a researcher requires deep pockets, the chair is forever. Chairs that are endowed this year will still be attracting top researchers and teachers in another hundred years.
Harnessing biotechnology for society’s benefit requires, first and foremost, a cadre of scientists. Genomics is a dynamic field. In order for HudsonAlpha to survive and thrive, we must generate more research results and discoveries. Hiring new faculty investigators will allow us to reach a critical mass of expertise, generate intellectual property, and most importantly, increase HudsonAlpha’s overall scientific impact and translation of genomics into practical applications.
In order to remain on the cutting edge of genomic sequencing, HudsonAlpha must invest in the most current sequencing technology and in the most effective and efficient methods of interpreting that sequencing data.
We must have funding for critical infrastructure – equipment and laboratories. We must support basic research that asks fundamental questions. Out of the crucible of basic research, we will generate new ideas and knowledge and address many of mankind’s challenges.
HudsonAlpha is founded on genomics research. Our researchers use genomics to explore and answer complex questions in our state-of-the-art research facility. To accomplish our goals, we must have funding for critical infrastructure, equipment and laboratories. Our research focuses on the following areas.

Breast. Prostate. Kidney. Ovarian. These cancers wreak a terrible toll. The lifetime risk of developing cancer is 1 in 2 for men and 1 in 3 for women. All cancers involve genetic changes, most of which are acquired, often by environmental exposures, not inherited. Genetic changes influence how fast the cancer grows, how likely it will spread, and what medications are most effective. Recent breakthroughs at HudsonAlpha include, for example, the ability to differentiate with genomic analysis which women with breast cancer will or will not respond to specific drug regimens.
Two out of every 100 children are born with intellectual or physical disability or developmental delay, many of which arise from genetic factors. The vast majority of these children and their families spend years seeking a specific diagnosis. Current technologies have only been capable of delivering diagnoses for 10 to 15 percent of affected children. The extended uncertainty of this diagnostic odyssey exacts a terrible toll on the families, adding to the already considerable medical, financial, and emotional distress. Revolutionary DNA sequencing and analysis, techniques which HudsonAlpha pioneered, are now being applied to families with affected children. Our techniques are significantly increasing rates of diagnosis, possibilities for treatment and even cures.
There are more than 600 neurological diseases. Collectively, Alzheimer disease, Parkinson disease, ALS, bipolar disorder, and autism spectrum disorder impact more than 16 million Americans worldwide. The risk factors for these diseases are poorly identified but evidence suggests multiple genetic and environmental factors, the combinations of which vary from individual to individual. HudsonAlpha is active in several cutting-edge consortiums to unlock these diseases’ mysteries.
The number of people suffering from psychiatric conditions is staggering. One in four Americans will experience some form of mental illness this year. Researchers at HudsonAlpha have outlined the chemical changes in the brain tissue of individuals affected with neuropsychiatric conditions like bipolar disorder and schizophrenia and have identified a series of chemical reactions in brain cells that are related to those disorders. Scientists are analyzing that information to learn more about psychiatric disease. HudsonAlpha is also a member of the Pritzker Neuropsychiatric Disorders Research Consortium, a group of research institutions that work together to discover the neurobiological and genetic causes of major depressive disorder, bipolar disorder and schizophrenia.
Using genomics technology to understand the human immune system and related diseases (such as lupus, rheumatoid arthritis, pancreatitis, psoriasis, and non-alcoholic fatty liver disease) is a burgeoning field. Immunogenomics brings together experts in genomics and genetics, immunology, bioinformatics and methodology, and clinical research in a search for biomarkers to guide diagnosis and treatment. It is increasingly clear that gene expression, regulatory sequences and large networks of genes, instead of single genes, are involved in autoimmune diseases. HudsonAlpha is at the forefront of this inquiry, with efforts that include organizing a bi-annual Immunogenomics symposium to explore how the immune system drives disease and how genomics might predict which patients should benefit most from new classes of drugs.
HudsonAlpha’s Genome Sequencing Center is one of only a handful of centers around the world that performs de novo sequencing of plants and organisms. In addition to bio-fuel plants and staple crops, such as soybean, cotton, cacao, and peaches, the center examines the genome of common pests that wreak havoc on harvests. HudsonAlpha leads advances in understanding plant-pathogen interactions, that is, how microbes, fungi and plants transfer genes between species. The center also works on the genomes of plant and animal species that are considered keystones in different ecosystems. Sustainable farming and environmental practices depend on the type of knowledge that HudsonAlpha generates.
As the field of genomics changes and grows, so must HudsonAlpha’s educational outreach efforts. With your help, Dr. Neil Lamb, Vice President for Educational Outreach, and his team can expand their popular programs, incorporate new technology, forge valuable partnerships, and develop additional innovative teaching methods as they work to inspire and train tomorrow’s biotech workforce.

BioTrain is HudsonAlpha’s signature summer internship program. We provide a variety of opportunities within BioTrain for high school through PhD students. These students have experiences as diverse as marketing, business strategy and in-depth laboratory research.
Participants in the APPLE (Advanced Placement Program for Learning Enhancement) program, a group of scientists and collegiate students, volunteer to bring the equipment, materials and resources needed to perform the Enzyme Catalysis and the Transformation labs for students at area high schools. The students interact with the volunteers and learn more about STEM-related careers. The teacher/student ratio for the laboratory exercises is increased, and the students are exposed to a number of different professional opportunities both in academia and industry. It is the goal of the program to have enough volunteers to work with the students on a 1:4 ratio. This program is free of charge to AP Biology classes in the Madison County metro area. The program runs from August to April of each school year.
HudsonAlpha’s popular public seminar series Biotech 101 is an introduction to the field of biotechnology and the influence of genetics on human health and disease. Offered each fall over four weekly sessions, participants are taught DNA basics and the relevance of genetics and genomics in medicine, agriculture and the environment. Biotech 201 is a follow-on course for those who have completed Biotech 101. It is offered each February as four weekly sessions. Each year’s Biotech 201 explores a different topic in genetics and genomics research. Sign up for the education newsletter to learn when registration begins. We rely on philanthropic support to keep these popular programs free to the public. Join the HudsonAlpha Alumni Association to help support the Biotech program.


For more information contact the HudsonAlpha Foundation at 

The HudsonAlpha Foundation, a 501(c)(3) nonprofit organization, is the supporting entity for the HudsonAlpha Institute for Biotechnology. Tax-deductible contributions to the foundation are for the sole purpose of advancing the mission of the HudsonAlpha Institute for Biotechnology. 

Tax identification #27-2320591